US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 3.2452
  • +0.1052+3.35%
Trading Apr 26 11:17 ET
34.04MMarket Cap-811P/E (TTM)

About NRX Pharmaceuticals Company

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Company Profile

SymbolNRXP
Company NameNRX Pharmaceuticals
Listing DateDec 1, 2017
Founded2017
CEOMr. Stephen H. Willard
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1201 Orange Street,Suite 600
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19801
Phone1-484-254-6134
Websitehttp://www.nrxpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen H. Willard
  • Director, Chief Executive Officer and Acting Corporate Secretary
  • 799.87K
  • Richard Clavano Narido
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Patrick J. Flynn
  • Chairman of our Board
  • 180.00K
  • Dr. Jonathan C. Javitt,M.D.,M.P.H.
  • Director and Chief Scientist
  • 873.70K
  • Dr. Sharon A. Glied, PhD
  • Independent Director
  • 160.00K
  • Aaron Gorovitz
  • Independent Director
  • 170.00K
  • Chaim Hurvitz
  • Independent Director
  • 160.00K
  • Riccardo Panicucci
  • CMC and Technical Operations Advisor
  • 240.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg